Tokai Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Tokai Pharmaceuticals Inc
CIK #0001404281
EDGAR Form CIK 2011 - 2026
10-K [0001404281]
10-Q [0001404281]
3 [0001404281]
4 [0001404281]
8-K [0001404281]
D [0001404281]
SC 13D [0001404281]
SC 13G [0001404281]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Eledon Pharmaceuticals Inc [2026-04-27]
Coastlands Capital LP Eledon Pharmaceuticals Inc [2025-11-24]
Vanguard Group Inc Eledon Pharmaceuticals Inc [2025-07-29]
BlackRock Inc Eledon Pharmaceuticals Inc [2025-07-17]
RA Capital Management LP Eledon Pharmaceuticals Inc [2024-11-05]
Frazier Life Sciences Public Fund LP Eledon Pharmaceuticals Inc [2024-11-05]
Armistice Capital LLC Eledon Pharmaceuticals Inc [2024-02-14]
Woodline Partners LP Eledon Pharmaceuticals Inc [2021-02-16]
FMR LLC Eledon Pharmaceuticals Inc [2021-02-08]
Adage Capital Partners GP LLC Eledon Pharmaceuticals Inc [2021-01-04]
Cormorant Asset Management LP Eledon Pharmaceuticals Inc [2021-01-04]
Logos Global Management LP Novus Therapeutics Inc [2020-11-09]
683 Capital Management LLC Novus Therapeutics Inc [2019-07-26]
Armistice Capital LLC Novus Therapeutics Inc [2019-06-05]
Biotechnology Value Fund L P Novus Therapeutics Inc [2019-05-10]
Lifesci Index Partners LLC Novus Therapeutics Inc [2018-03-13]
Nussbaum Ran Novus Therapeutics Inc [2017-05-25]
Peregrine Ventures Management Ltd Novus Therapeutics Inc [2017-05-22]
OrbiMed Israel BioFund GP Limited Partnership Novus Therapeutics Inc [2017-05-19]
OTIC Pharma Ltd Tokai Pharmaceuticals Inc [2017-01-05]
Satter Muneer A Tokai Pharmaceuticals Inc [2015-02-12]
Novo A/S Tokai Pharmaceuticals Inc [2014-10-22]
Novartis BioVentures Ltd Tokai Pharmaceuticals Inc [2014-10-01]
Apple Tree Partners II LP Tokai Pharmaceuticals Inc [2014-09-30]
Form 3/4/5 Subject 2011 - 2026
Tokai Pharmaceuticals Inc
McBride John S
Robinson James A Jr
Lee June
Katkin Keith
Kirk Allan
Hillson Jan
Smith Bryan E
Gros David-Alexandre C
Little Paul Sean
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 8,575 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 8,575 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2025-01-10 Grant 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
2025-01-10 Grant 30,870 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2025-01-10 Grant 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
2025-01-10 Grant 30,870 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2025-01-10 Grant 66,500 $0.00
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
2025-01-10 Grant 600,000 $0.00
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
2025-01-10 Grant 150,500 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2025-01-10 Grant 64,500 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com